Ryan Andrew Adams,Luke Burman,Yeeting Chong,David King,John D. Mendlein,Leslie Nangle Greene,Kathleen Ogilvie,Kaitlyn Rauch
申请号：
US15828170
公开号：
US20180282402A1
申请日:
2017.11.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided are antibodies that specifically bind to human histidyl-tRNA synthetase and related therapeutic compositions and methods for treating cancer, including as standalone therapies or in combination with cancer immunotherapies, for example, immune checkpoint modulators such as PD-1 inhibitors.
